Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA -0.4EWJ 0.37TECK.B.TO -2.09CNQ.TO 0.71HHL.TO 0.075SYLD 0.03HAC.TO 0.04TRU -0.01
Daily Stock Opinions and Ratings
The ultimate 360° Tracker Your financial life in one place, automatically
Stockchase Opinions

Don LatoHorizon's Medical MarijuanaHMMJ.TOCOMMENTDec 21, 2018

He is not an expert in cannabis. There will be real industry going forward and some companies will prosper in the long term. The valuations still remain excessive. If he were to participate it would be with Canopy Growth as they have a connection with Constellation Brands in the US.
Don LatoDon Lato
No
Unlock Rating
$14.04

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

TOP PICK

Horizon's Medical Marijuana(HMMJ.TO)

Sep 12, 2023

This asset class has been down for 5 years during a long period of investor apathy. But when an asset class has been down for longer than 3 years, you start to consider it. HMMJ has US exposure where there is growing public support for legalizing canopy. Maybe start with a small position. This is a volatile sector.

Photo of Mike PhilbrickMike Philbrick
No
Unlock Rating
$11.39

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
DON'T BUY

Horizon's Medical Marijuana(HMMJ.TO)

Sep 27, 2021
Are you investing or gambling? Some invest in hot sectors like cannabis or blockchain without understanding them. He's never owned this, because it's gambling. He avoids the sector for the same reason.
Photo of John HoodJohn Hood
No
Unlock Rating
$8.08

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
DON'T BUY

Horizon's Medical Marijuana(HMMJ.TO)

Feb 03, 2021
Wouldn't buy. Firstly on principle, as they're active managers. The ETF owns the good, the bad, and the ugly. There are a lot of garbagy business models and bottom feeders out there.
Photo of Brian MaddenBrian Madden
No
Unlock Rating
$13.97

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
BUY ON WEAKNESS

Horizon's Medical Marijuana(HMMJ.TO)

Jun 12, 2020
The yield is not a dividend. Because of M&A, there is a capital distribution every year. Long term CBDs are going to be a big part of the future. It could be an election issue in the US. These companies don't make any money so it is speculative. He likes it longer term.
Photo of Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTA
Owned
Unlock Rating
$7.28

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
PARTIAL BUY

Horizon's Medical Marijuana(HMMJ.TO)

May 29, 2020
He started to nibble. Expect a lot of volatility. He likes it on valuation.
Photo of Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTA
Owned
Unlock Rating
$8.01

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
PARTIAL BUY

Horizon's Medical Marijuana(HMMJ.TO)

Jan 13, 2020
He has said for a couple of years that he wants the industry to mature. He thinks there is some value there at this point. There are really no earnings, however. Usually when a correction hits, stocks without earnings get hit first. He has been buying below $9. Don't commit a lot of money. Just nibble.
Photo of Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTAUnlock Rating
$8.25

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
DON'T BUY

Horizon's Medical Marijuana(HMMJ.TO)

Jan 02, 2020
Not just discouraging performance, but catastrophic. None of these things are making any money. He won't be buying in this sector. He likes earnings.
Photo of John HoodJohn Hood
No
Unlock Rating
$8.75

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
DON'T BUY

Horizon's Medical Marijuana(HMMJ.TO)

Dec 23, 2019
The problem he has with this is that you can't get capacity. He stays away from it.
Photo of Hap (Robert) Sneddon FCSIHap (Robert) Sneddon FCSI
No
Unlock Rating
$8.97

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
DON'T BUY

Horizon's Medical Marijuana(HMMJ.TO)

Nov 04, 2019
He's never liked marijuana stocks. The hype wasn't justified and they got way ahead of themselves. This will be regulated like alcohol which means tight returns.
Photo of Richard CroftRichard CroftUnlock Rating
$10.50

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
DON'T BUY

Horizon's Medical Marijuana(HMMJ.TO)

Sep 06, 2019
Marijuana stocks There has been a sell off because of Canntrust and no one is making money. There will be a lot of research to be done on the benefits. However, the best days to make profit here are probably behind us.
Photo of Darren SissonsDarren Sissons
No
Unlock Rating
$15.20

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
BUY ON WEAKNESS

Horizon's Medical Marijuana(HMMJ.TO)

Sep 05, 2019
Anytime you are investing in an area with such massive potential growth opportunities, you will see volatility. If you buy a little and more yet in corrections, it is a way to play it. Wait for good stiff corrections.
Photo of Mike PhilbrickMike PhilbrickUnlock Rating
$14.95

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
BUY

Horizon's Medical Marijuana(HMMJ.TO)

Aug 01, 2019

HMMJ vs. HMUS. A monstrous opportunity, but you're going to suffer volatility. Go slow, get in over time, and keep it to a smaller proportion of your portfolio. Market weighted. The US exposure is to companies operating legally, and there can't be any recreational use. With HMUS, you're tapping into a bigger market. For example, Charlotte's Web is planning to sell CBD infused products through Kroeger. This scale dwarfs the whole Canadian market. Valuations are high because of the growth potential. If you're a marijuana investing aficionado, you'd want to own both.

Photo of Mike PhilbrickMike PhilbrickUnlock Rating
$15.81

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
COMMENT

Horizon's Medical Marijuana(HMMJ.TO)

Jun 12, 2019
Any vice will do well, and so will this. Horizon makes great ETFs. That said, ETF's aren't always the best. Instead of buying the weed basket, buy the leader--Canopy.
Photo of Terry ShaunessyTerry ShaunessyUnlock Rating
$19.09

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
DON'T BUY

Horizon's Medical Marijuana(HMMJ.TO)

Jun 03, 2019
Companies on this don't have any earnings. With out earnings he doesn't want it.
Photo of John HoodJohn Hood
No
Unlock Rating
$17.99

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s
COMMENT

Horizon's Medical Marijuana(HMMJ.TO)

May 09, 2019
How does this pay a yield if weed stocks don't? It does pay a dividend, perhaps from capital gains from buying and selling those weed stocks within the ETF. He doesn't think cannabis will be an exciting industry, but will wind up like the liquor business.
Photo of Richard CroftRichard CroftUnlock Rating
$19.97

Stock price when the opinion was issued

$7.29

As of Jun 19, 2026. Market Open.

E.T.F.'s

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV 0$153.3
WSP.TO 1.13$176.7
VRTX 0.47$452.1
OTEX.TO 0.24$29.47
CCO.TO 0.61$151.07

Today's Top Picks

NVDA -0.4$210.29
EWJ 0.37$96.63
TECK.B.T… -2.09$88.93
CNQ.TO 0.71$58.66
HHL.TO 0.075$6.865

Popular Articles

Latest Sell Signals

TD.TO 0.7$169.33
MBLY -0.03$8.43
ASAN 0.03$6.95
MODG -0.01$18.21
NVTS 0$24.02

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica